These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4266330)

  • 21. Serum total tryptophan and free tryptophan concentration in Down's syndrome its relation to serum serotonin concentration.
    Hoshino Y; Kaneko M; Yashima Y; Kumashiro H
    Fukushima J Med Sci; 1980 Jun; 27(1-2):39-51. PubMed ID: 6460675
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB; Strauss D
    J Insur Med; 1997; 29(3):172-84. PubMed ID: 10176367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.
    Maccario R; Ugazio AG; Nespoli L; Alberini C; Montagna D; Porta F; Bonetti F; Burgio GR
    Clin Exp Immunol; 1984 Jul; 57(1):220-6. PubMed ID: 6235075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on sex-dimorphism of peripheral blood granulocytes in the Langdon-Down syndrome].
    Dobrzańska A; Gajewska E
    Pol Tyg Lek; 1967 Dec; 22(49):1879-83. PubMed ID: 4233241
    [No Abstract]   [Full Text] [Related]  

  • 25. [Radiosensitivity of chromosomes in lymphocytes from Down's syndrome patients].
    Akif'ev AP; Mutovin GR; Filiushkin IV; Khandogina EK
    Biull Eksp Biol Med; 1983 Dec; 96(12):69-71. PubMed ID: 6229291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial Down's syndrome.
    Maximilian C; Pop T; Duca D; Simionescu L; Danielescu M; Ioan D
    Endocrinologie; 1981; 19(1):65-8. PubMed ID: 6457382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the hyposegmentation of the neutrophile granulocytes in Down's syndrome].
    Dallapiccola B
    Haematologica; 1967; 52(2):121-31. PubMed ID: 4238213
    [No Abstract]   [Full Text] [Related]  

  • 28. Blastic response of lymphocytes in mosaic Down's syndrome under serial PHA dilutions.
    Matte R; Sasaki M; Obara Y
    Jinrui Idengaku Zasshi; 1969 Sep; 14(2):160-2. PubMed ID: 4244063
    [No Abstract]   [Full Text] [Related]  

  • 29. A survey of 972 cytogenetically examined cases of Down's syndrome.
    Gardner RJ; Veale AM; Parslow MI; Becroft DM; Shaw RL; Fitzgerald PH; Hutchings HE; McCreanor HR; Wong J; Eiby JR; Howarth DA; Whyte SE
    N Z Med J; 1973 Nov; 78(502):403-9. PubMed ID: 4272131
    [No Abstract]   [Full Text] [Related]  

  • 30. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Middle ear effusion in Down's syndrome patients.
    Samuelson ME; Nguyen VT
    Nebr Med J; 1980 Apr; 65(4):83-4. PubMed ID: 6445043
    [No Abstract]   [Full Text] [Related]  

  • 32. Ocular health status of subjects with Down's syndrome in Benin City, Nigeria.
    Ebeigbe JA; Akpalaba R
    Afr J Med Med Sci; 2006 Sep; 35(3):365-8. PubMed ID: 17312746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ["E" and "EAC" rosette tests of peripheral blood in children with Down's syndrome].
    Kobielowa Z; Pietrzyk J; Mytar B; Mitkowska Z
    Pediatr Pol; 1980 May; 55(5):609-15. PubMed ID: 6447268
    [No Abstract]   [Full Text] [Related]  

  • 34. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
    Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil viability in Down's syndrome.
    Cocchi P; Silenzi M; Ravina A
    JAMA; 1978 Aug; 240(8):737. PubMed ID: 149866
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies of granulopoiesis and granulocyte kinetics in Down's syndrome.
    Pearson HA
    Pediatrics; 1967 Jul; 40(1):92-5. PubMed ID: 4226372
    [No Abstract]   [Full Text] [Related]  

  • 38. Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an "atheroma-free model": Down's syndrome.
    Goi G; Baquero-Herrera C; Licastro F; Dogliotti G; Corsi MM
    Int J Cardiol; 2006 Nov; 113(3):427-9. PubMed ID: 16343667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.
    Karttunen R; Nurmi T; Ilonen J; Surcel HM
    Clin Exp Immunol; 1984 Feb; 55(2):257-63. PubMed ID: 6230181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diminished zinc plasma concentrations and alterations in the number of lymphocyte subpopulations in Down's syndrome patients].
    Soto-Quintana M; Alvarez-Nava F; Rojas-Atencio A; Granadillo V; Fernández D; Ocando A; López E; Fulcado W
    Invest Clin; 2003 Mar; 44(1):51-60. PubMed ID: 12703183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.